Lv7
4860 积分 2021-10-25 加入
Prognostic risk factors and a survival prediction model for immune checkpoint inhibitor related myocarditis in patients with lung cancer: a multicenter study
1个月前
已完结
Reply
1个月前
已完结
Immune checkpoint inhibitor–associated myocarditis: Incidence, risk factors, and clinical outcomes in a global real-world cohort
1个月前
已完结
Overlapping Syndrome of Myocarditis, Myositis, Transaminitis, and Myasthenia Gravis in a Patient with Hepatocellular Carcinoma after Treatment with Immune Checkpoint Inhibitors: A Case Report and Literature Review
1个月前
已关闭
Relationship between Podocyte Injury and Renal Outcomes in Patients with Acute Kidney Injury: A Report from a Retrospective Study in China
1个月前
已完结
Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia
1个月前
已完结
Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing
1个月前
已完结
A review of immune checkpoint inhibitor-associated myocarditis: Epidemiology, pathogenesis, and biomarkers
1个月前
已完结
2025 ESC Guidelines for the management of myocarditis and pericarditis
1个月前
已完结
How should immune checkpoint inhibitor myocarditis be treated?
1个月前
已完结
皖公网安备34019202002308
